Balchem Stock

Balchem Equity

The The Equity of Balchem (BCPC) as of Aug 1, 2026 is 1.26 B USD. In the previous year, The Equity was 1.15 B USD — a change of 9.35% (higher).

Equity

1.26 BUSD

YoY

9.35%

Last updated:

In 2026, Balchem's equity was 1.26 B USD, a 9.35% increase from the 1.15 B USD equity in the previous year.

Access this data via the Eulerpool API

Balchem Stock analysis

What does Balchem do? Balchem Corp is a US-based company specialized in the manufacture and sale of chemical additives and ingredients for a variety of industries. The company was founded in 1967 and is headquartered in New York. Balchem Corp offers a wide range of products and services, divided into different divisions. The largest divisions are Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. In the Human Nutrition & Health division, Balchem produces ingredients for use in functional foods, supplements, beverages, and other health products. The Animal Nutrition & Health division manufactures animal feed additives aimed at improving the health and growth of livestock. The Specialty Products division produces specialty chemicals for a variety of applications. Balchem Corp is also specialized in the development of fragrances and flavors. Balchem has become one of the leading manufacturers of amino acid derivatives, providing high-quality solutions for veterinary applications. Balchem Corp's history is characterized by expansion and diversification. In its early years, the company focused on the manufacture of chemical additives for the agriculture industry. One of Balchem's first achievements was the development of an additive that prevents feed from molding during transportation and storage. Over the years, Balchem has continuously expanded its offerings and now has a broad product portfolio serving many different industries. Balchem's expansion continued in the 1990s when the company started to expand its business into the human nutrition sector. Today, the Human Nutrition & Health division is the company's fastest-growing segment. Similar to the animal nutrition industry, Balchem also offers a variety of ingredients in this sector that have higher nutrient density and/or better bioavailability than conventional foods. In recent years, Balchem Corp has shown strong growth dynamics. In 2019, the company had a revenue of nearly $650 million. The company has been listed on NASDAQ since 1997 and has continuously increased its market value in recent years. Overall, Balchem Corp is an innovative and diversified company specialized in the manufacture of chemical additives and ingredients for various industries. The company has shown strong growth dynamics over the years and has continuously expanded its portfolio to meet the changing needs of its customers. With its broad product lines divided into different divisions, Balchem has solidified its position as a leading provider of additives and ingredients in many industries. Balchem Corp is a US-based company specialized in the manufacture and sale of chemical additives and ingredients for a variety of industries. Balchem is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Balchem's Equity

Balchem's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Balchem's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Balchem's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Balchem's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Balchem’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Balchem stock

The Equity of Balchem is 1.26 B USD in 2026.

Access this data via the Eulerpool API

Balance Sheet — Balchem

All Key Metrics — Balchem